Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Value of CD45Ro+ T-Cell Expression in Patients With Oral Squamous Cell Carcinoma

KAZUSHIGE KOIKE, KOYO NISHIYAMA, HIRONARI DEHARI, KAZUHIRO OGI, TAKANORI SASAKI, SHOTA SHIMIZU, TAKASHI SASAYA, KEI TSUCHIHASHI, TOMOKO SONODA, TADASHI HASEGAWA, HIROYOSHI HIRATSUKA and AKIHIRO MIYAZAKI
Anticancer Research September 2021, 41 (9) 4515-4522; DOI: https://doi.org/10.21873/anticanres.15262
KAZUSHIGE KOIKE
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kkoike0922@gmail.com
KOYO NISHIYAMA
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIRONARI DEHARI
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIRO OGI
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKANORI SASAKI
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHOTA SHIMIZU
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI SASAYA
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEI TSUCHIHASHI
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOKO SONODA
2Department of Public Health, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADASHI HASEGAWA
3Department of Surgical Pathology, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYOSHI HIRATSUKA
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
4Department of Oral and Maxillo-Facial Surgery, Toya Kyokai Hospital, Hokkaido, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHIRO MIYAZAKI
1Department of Oral Surgery, Sapporo Medical University School of Medicine, Hokkaido, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The role of tumour-infiltrating CD45Ro+ T-cells in oral squamous cell carcinoma (OSCC) is unclear. This study aimed to evaluate prognostic biomarkers for OSCC. Patients and Methods: We determined the density of tumour-infiltrating CD45Ro+ T cells in the parenchyma and stroma at the tumour centre (TCe) and invasive front (IF) and examined the association between the density of these cells and histopathological status in 142 patients. Results: Five-year overall survival (OS) and recurrence-free survival were favourable in patients with high CD45Ro+ T-cell density in the TCe stroma. OS was favourable in patients with high CD45Ro+ T-cell density in the IF stroma. Stepwise Cox regression model analysis indicated that CD45Ro+ T-cells in the stroma of the IF and TCe were an independent prognostic factor for OS. Conclusion: CD45Ro+ T-cells in the stroma of the IF and TCe play a role in cancer immune surveillance and may be a useful prognostic factor.

Key Words:
  • Tumour-infiltrating lymphocytes
  • oral cancer
  • biomarker
  • CD45Ro
  • prognosis
  • Received May 31, 2021.
  • Revision received June 29, 2021.
  • Accepted July 8, 2021.
  • Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 41 (9)
Anticancer Research
Vol. 41, Issue 9
September 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Value of CD45Ro+ T-Cell Expression in Patients With Oral Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Value of CD45Ro+ T-Cell Expression in Patients With Oral Squamous Cell Carcinoma
KAZUSHIGE KOIKE, KOYO NISHIYAMA, HIRONARI DEHARI, KAZUHIRO OGI, TAKANORI SASAKI, SHOTA SHIMIZU, TAKASHI SASAYA, KEI TSUCHIHASHI, TOMOKO SONODA, TADASHI HASEGAWA, HIROYOSHI HIRATSUKA, AKIHIRO MIYAZAKI
Anticancer Research Sep 2021, 41 (9) 4515-4522; DOI: 10.21873/anticanres.15262

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Value of CD45Ro+ T-Cell Expression in Patients With Oral Squamous Cell Carcinoma
KAZUSHIGE KOIKE, KOYO NISHIYAMA, HIRONARI DEHARI, KAZUHIRO OGI, TAKANORI SASAKI, SHOTA SHIMIZU, TAKASHI SASAYA, KEI TSUCHIHASHI, TOMOKO SONODA, TADASHI HASEGAWA, HIROYOSHI HIRATSUKA, AKIHIRO MIYAZAKI
Anticancer Research Sep 2021, 41 (9) 4515-4522; DOI: 10.21873/anticanres.15262
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan
  • Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
  • Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National Cancer Database
Show more Clinical Studies

Similar Articles

Keywords

  • Tumour-infiltrating lymphocytes
  • oral cancer
  • biomarker
  • CD45Ro
  • prognosis
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire